非血管支架的全球市場

全球非血管支架的市場規模在2020年∼2027年的分析期間中預計將以4.9％的年複合成長率增長，從2020年的10億美元到2027年達到14億美元。本報告市場區隔之一的消化管支架部門在分析期間結束前預測將以5.5％的年率增長，達到5億2,960萬美元。

本報告提供全球非血管支架市場的相關調查，提供市場佔有率，趨勢和預測，成長要素，各地區的市場分析，競爭情形，主要企業的簡介等資訊。

調查對象企業範例

• BARD, A Becton, Dickinson Company
• Boston Scientific Corporation
• ConMed Corporation
• Cook Medical, Inc.
• ELLA-CS, s.r.o.
• Glaukos Corporation
• Hobbs Medical, Inc.
• Medtronic PLC
• Synchron, Inc.
• Taewoong Medical

目錄

I. 簡介，調查手法，調查範圍

II. 摘要整理

• 市場概要
  • 競爭的市場佔有率
  • 競爭的市場佔有率方案
  • Covid-19的影響和即將到來的全球景氣衰退
• 主要企業
• 趨勢與成長要素
• 全球市場預測

III. 市場分析

• 各地區市場分析
• 美國
• 加拿大
• 日本
• 中國
• 歐洲
• 法國
• 德國
• 義大利
• 英國
• 其他歐洲
• 亞太地區
• 其他地區

IV. 競爭

• 企業簡介:44公司

Abstract:

Global Non-vascular Stents Market to Reach $1.4 Billion by 2027

Amid the COVID-19 crisis, the global market for Non-vascular Stents estimated at US$1 Billion in the year 2020, is projected to reach a revised size of US$1.4 Billion by 2027, growing at a CAGR of 4.9% over the analysis period 2020-2027. Gastrointestinal Stents, one of the segments analyzed in the report, is projected to record a 5.5% CAGR and reach US$529.6 Million by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Pulmonary Stents segment is readjusted to a revised 4.2% CAGR for the next 7-year period.

The U.S. Market is Estimated at $302.7 Million, While China is Forecast to Grow at 4.6% CAGR

The Non-vascular Stents market in the U.S. is estimated at US$302.7 Million in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$253.2 Million by the year 2027 trailing a CAGR of 4.6% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 4.6% and 4% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 4.5% CAGR.

Urology Stents Segment to Record 4.8% CAGR

In the global Urology Stents segment, USA, Canada, Japan, China and Europe will drive the 4.9% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$329.8 Million in the year 2020 will reach a projected size of US$462.5 Million by the close of the analysis period. China will remain among the fastest growing in this cluster of regional markets. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$159.5 Million by the year 2027.

Select Competitors (Total 44 Featured) -

• BARD, A Becton, Dickinson Company
• Boston Scientific Corporation
• ConMed Corporation
• Cook Medical, Inc.
• ELLA-CS, s.r.o.
• Glaukos Corporation
• Hobbs Medical, Inc.
• Medtronic PLC
• Synchron, Inc.
• Taewoong Medical

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

• 1. MARKET OVERVIEW
  • Influencer Market Insights
  • World Market Trajectories
  • Impact of Covid-19 and a Looming Global Recession
• 2. FOCUS ON SELECT PLAYERS
• 3. MARKET TRENDS & DRIVERS
• 4. GLOBAL MARKET PERSPECTIVE
  • TABLE 1: World Current & Future Analysis for Non-vascular Stents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
  • TABLE 2: World Historic Review for Non-vascular Stents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
  • TABLE 3: World 15-Year Perspective for Non-vascular Stents by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2012, 2020 & 2027
  • TABLE 4: World Current & Future Analysis for Gastrointestinal Stents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
  • TABLE 5: World Historic Review for Gastrointestinal Stents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
  • TABLE 6: World 15-Year Perspective for Gastrointestinal Stents by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027
  • TABLE 7: World Current & Future Analysis for Pulmonary Stents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
  • TABLE 8: World Historic Review for Pulmonary Stents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
  • TABLE 9: World 15-Year Perspective for Pulmonary Stents by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027
  • TABLE 10: World Current & Future Analysis for Urology Stents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
  • TABLE 11: World Historic Review for Urology Stents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
  • TABLE 12: World 15-Year Perspective for Urology Stents by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027
  • TABLE 13: World Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
  • TABLE 14: World Historic Review for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
  • TABLE 15: World 15-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027

III. MARKET ANALYSIS

• UNITED STATES
  • TABLE 16: USA Current & Future Analysis for Non-vascular Stents by Application - Gastrointestinal Stents, Pulmonary Stents, Urology Stents and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
  • TABLE 17: USA Historic Review for Non-vascular Stents by Application - Gastrointestinal Stents, Pulmonary Stents, Urology Stents and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
  • TABLE 18: USA 15-Year Perspective for Non-vascular Stents by Application - Percentage Breakdown of Value Sales for Gastrointestinal Stents, Pulmonary Stents, Urology Stents and Other Applications for the Years 2012, 2020 & 2027
• CANADA
  • TABLE 19: Canada Current & Future Analysis for Non-vascular Stents by Application - Gastrointestinal Stents, Pulmonary Stents, Urology Stents and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
  • TABLE 20: Canada Historic Review for Non-vascular Stents by Application - Gastrointestinal Stents, Pulmonary Stents, Urology Stents and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
  • TABLE 21: Canada 15-Year Perspective for Non-vascular Stents by Application - Percentage Breakdown of Value Sales for Gastrointestinal Stents, Pulmonary Stents, Urology Stents and Other Applications for the Years 2012, 2020 & 2027
• JAPAN
  • TABLE 22: Japan Current & Future Analysis for Non-vascular Stents by Application - Gastrointestinal Stents, Pulmonary Stents, Urology Stents and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
  • TABLE 23: Japan Historic Review for Non-vascular Stents by Application - Gastrointestinal Stents, Pulmonary Stents, Urology Stents and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
  • TABLE 24: Japan 15-Year Perspective for Non-vascular Stents by Application - Percentage Breakdown of Value Sales for Gastrointestinal Stents, Pulmonary Stents, Urology Stents and Other Applications for the Years 2012, 2020 & 2027
• CHINA
  • TABLE 25: China Current & Future Analysis for Non-vascular Stents by Application - Gastrointestinal Stents, Pulmonary Stents, Urology Stents and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
  • TABLE 26: China Historic Review for Non-vascular Stents by Application - Gastrointestinal Stents, Pulmonary Stents, Urology Stents and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
  • TABLE 27: China 15-Year Perspective for Non-vascular Stents by Application - Percentage Breakdown of Value Sales for Gastrointestinal Stents, Pulmonary Stents, Urology Stents and Other Applications for the Years 2012, 2020 & 2027
• EUROPE
  • TABLE 28: Europe Current & Future Analysis for Non-vascular Stents by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
  • TABLE 29: Europe Historic Review for Non-vascular Stents by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
  • TABLE 30: Europe 15-Year Perspective for Non-vascular Stents by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2012, 2020 & 2027
  • TABLE 31: Europe Current & Future Analysis for Non-vascular Stents by Application - Gastrointestinal Stents, Pulmonary Stents, Urology Stents and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
  • TABLE 32: Europe Historic Review for Non-vascular Stents by Application - Gastrointestinal Stents, Pulmonary Stents, Urology Stents and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
  • TABLE 33: Europe 15-Year Perspective for Non-vascular Stents by Application - Percentage Breakdown of Value Sales for Gastrointestinal Stents, Pulmonary Stents, Urology Stents and Other Applications for the Years 2012, 2020 & 2027
• FRANCE
  • TABLE 34: France Current & Future Analysis for Non-vascular Stents by Application - Gastrointestinal Stents, Pulmonary Stents, Urology Stents and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
  • TABLE 35: France Historic Review for Non-vascular Stents by Application - Gastrointestinal Stents, Pulmonary Stents, Urology Stents and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
  • TABLE 36: France 15-Year Perspective for Non-vascular Stents by Application - Percentage Breakdown of Value Sales for Gastrointestinal Stents, Pulmonary Stents, Urology Stents and Other Applications for the Years 2012, 2020 & 2027
• GERMANY
  • TABLE 37: Germany Current & Future Analysis for Non-vascular Stents by Application - Gastrointestinal Stents, Pulmonary Stents, Urology Stents and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
  • TABLE 38: Germany Historic Review for Non-vascular Stents by Application - Gastrointestinal Stents, Pulmonary Stents, Urology Stents and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
  • TABLE 39: Germany 15-Year Perspective for Non-vascular Stents by Application - Percentage Breakdown of Value Sales for Gastrointestinal Stents, Pulmonary Stents, Urology Stents and Other Applications for the Years 2012, 2020 & 2027
• ITALY
  • TABLE 40: Italy Current & Future Analysis for Non-vascular Stents by Application - Gastrointestinal Stents, Pulmonary Stents, Urology Stents and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
  • TABLE 41: Italy Historic Review for Non-vascular Stents by Application - Gastrointestinal Stents, Pulmonary Stents, Urology Stents and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
  • TABLE 42: Italy 15-Year Perspective for Non-vascular Stents by Application - Percentage Breakdown of Value Sales for Gastrointestinal Stents, Pulmonary Stents, Urology Stents and Other Applications for the Years 2012, 2020 & 2027
• UNITED KINGDOM
  • TABLE 43: UK Current & Future Analysis for Non-vascular Stents by Application - Gastrointestinal Stents, Pulmonary Stents, Urology Stents and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
  • TABLE 44: UK Historic Review for Non-vascular Stents by Application - Gastrointestinal Stents, Pulmonary Stents, Urology Stents and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
  • TABLE 45: UK 15-Year Perspective for Non-vascular Stents by Application - Percentage Breakdown of Value Sales for Gastrointestinal Stents, Pulmonary Stents, Urology Stents and Other Applications for the Years 2012, 2020 & 2027
• REST OF EUROPE
  • TABLE 46: Rest of Europe Current & Future Analysis for Non-vascular Stents by Application - Gastrointestinal Stents, Pulmonary Stents, Urology Stents and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
  • TABLE 47: Rest of Europe Historic Review for Non-vascular Stents by Application - Gastrointestinal Stents, Pulmonary Stents, Urology Stents and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
  • TABLE 48: Rest of Europe 15-Year Perspective for Non-vascular Stents by Application - Percentage Breakdown of Value Sales for Gastrointestinal Stents, Pulmonary Stents, Urology Stents and Other Applications for the Years 2012, 2020 & 2027
• ASIA-PACIFIC
  • TABLE 49: Asia-Pacific Current & Future Analysis for Non-vascular Stents by Application - Gastrointestinal Stents, Pulmonary Stents, Urology Stents and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
  • TABLE 50: Asia-Pacific Historic Review for Non-vascular Stents by Application - Gastrointestinal Stents, Pulmonary Stents, Urology Stents and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
  • TABLE 51: Asia-Pacific 15-Year Perspective for Non-vascular Stents by Application - Percentage Breakdown of Value Sales for Gastrointestinal Stents, Pulmonary Stents, Urology Stents and Other Applications for the Years 2012, 2020 & 2027
• REST OF WORLD
  • TABLE 52: Rest of World Current & Future Analysis for Non-vascular Stents by Application - Gastrointestinal Stents, Pulmonary Stents, Urology Stents and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
  • TABLE 53: Rest of World Historic Review for Non-vascular Stents by Application - Gastrointestinal Stents, Pulmonary Stents, Urology Stents and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
  • TABLE 54: Rest of World 15-Year Perspective for Non-vascular Stents by Application - Percentage Breakdown of Value Sales for Gastrointestinal Stents, Pulmonary Stents, Urology Stents and Other Applications for the Years 2012, 2020 & 2027

IV. COMPETITION

• Total Companies Profiled: 44